Atrium is a biopharmaceutical company pioneering delivery of RNA therapeutics to the heart to transform the standard of care for people living with cardiomyopathies. Our proprietary technology leverages the targeted RNA delivery platform initially designed at Avidity, which combines the tissue selectivity of mAbs and other targeted delivery ligands with the precision of oligonucleotides. This unique combination is designed to allow selective targeting of the underlying genetic drivers of disease that were previously undruggable. Through targeted, non-viral delivery of siRNA to cardiac tissues, our approach has the potential to overcome key limitations of nonspecific viral and nanoparticle-based delivery systems, including challenges related to tissue specificity, immunogenicity, and redosing. Position Overview: Reporting directly to the Chief Strategy Officer, the Senior Director of Market Readiness & Medical Strategy is a newly created role within Atrium’s Strategy office. This person will serve as the connective tissue between medical strategy, disease ecosystem development, and market shaping — building the external stakeholder infrastructure and internal strategic frameworks needed to bring Atrium’s programs to patients. This is a high-impact individual contributor role suited to someone who operates at the strategic level and rolls up their sleeves to execute. You will have significant autonomy, direct access to senior leadership, and the opportunity to build programs that define how Atrium shows up in the rare cardiomyopathy field. At Atrium, we move with urgency and intellectual rigor, and we believe that AI-augmented ways of working are not a future ambition but a present standard. Every member of our team is expected to embrace emerging tools and technologies as a natural part of how we think, research, and execute
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior